An improved conjugate vaccine technology; induction of antibody responses to the tumor vasculature
Contributeurs/tricesHuijbers, Elisabeth J M; van Beijnum, Judy R; Lê, Chung T; Langman, Sofya; Nowak-Sliwinska, Patrycja; Mayo, Kevin H; Griffioen, Arjan W
Publié dansVaccine, vol. 36, no. 21, p. 3054-3060
Date de publication2018
Résumé
Mots-clés
- Animals
- Antibodies, Neoplasm/blood
- Antigens, Bacterial/genetics/immunology
- Autoantigens/genetics/immunology
- Bacterial Proteins/genetics/immunology
- Cancer Vaccines/administration & dosage/immunology
- Female
- Fibronectins/genetics/immunology
- Fibrosarcoma/pathology
- Immunohistochemistry
- Mice, Inbred C57BL
- Neoplasms/therapy
- Vaccines, Conjugate/administration & dosage/immunology
Structure d'affiliation
Groupe de recherche
Citation (format ISO)
HUIJBERS, Elisabeth J M et al. An improved conjugate vaccine technology; induction of antibody responses to the tumor vasculature. In: Vaccine, 2018, vol. 36, n° 21, p. 3054–3060. doi: 10.1016/j.vaccine.2018.03.064
Fichiers principaux (1)
Article (Published version)
Correctifs (1)
Erratum
Identifiants
- PID : unige:138154
- DOI : 10.1016/j.vaccine.2018.03.064
- PMID : 29655625
ISSN du journal0264-410X